Skip to main content

Advertisement

Log in

Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion

  • Research Paper
  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Dickkopf-1 (DKK1) was known as a negative regulator of the Wnt signaling pathway, which played a crucial role in carcinogenesis. However, its function in human cancers remained elusive. In this study, we aimed to investigate the role of DKK1 in ovarian serous papillary adenocarcinoma (OSC) tumor progression and invasion. Quantitative real-time RT–PCR and Western blot analysis showed that the expression of DKK1 mRNA and protein in 32 OSC tissues were elevated as compared with those in 10 normal ovarian tissues (P = 0.005, P = 0.003, respectively). Immunohistochemical analysis in 178 clinical OSC samples showed that the expression of DKK1 was positively associated with FIGO stage (P = 0.016). Furthermore, the expression of DKK1 protein was positively associated with P-JNK1 protein expression in 178 OSC tissues. DKK1, P-JNK1 and the co-expression of DKK1 and P-JNK1 were all unfavorable prognosis factors for OSC patients (P < 0.0001). DKK1, alone or combined with P-JNK1, was an independent predictor for the 5 year survival (P = 0.015, P < 0.0001, respectively). DKK1 could promote OSC cells invasion and the growth of OSC nude mice xenograft. DKK1 in OSC cells could activate P-JNK1 expression and significantly promote formations of actin filaments and filopodia. Thus, DKK1, alone or combined with P-JNK1, was a novel prognostic predictor for OSC patients and contributed to the invasion of OSC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

Abbreviations

DKK1:

Dickkopf-1

OSC:

Ovarian serous papillary adenocarcinoma

P-JNK1:

Phosphorylation of JNK1

qRT–PCR:

Quantitative real-time RT–PCR

FIGO:

Federation International of Gynecology and Obstetrics

SD:

Standard deviation

TV:

Tumor volume

References

  1. Peifer M, Polakis P (2000) Wnt signaling in oncogenesis and embryogenesis—a look outside the nucleus. Science 287:1606–1609

    Article  PubMed  CAS  Google Scholar 

  2. Polakis P (2007) The many ways of Wnt in cancer. Curr Opin Genet Dev 7:45–51

    Article  Google Scholar 

  3. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20:781–810

    Article  PubMed  CAS  Google Scholar 

  4. Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469–7481

    Article  PubMed  CAS  Google Scholar 

  5. Krupnik VE, Sharp JD, Jiang C et al (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238:301–313

    Article  PubMed  CAS  Google Scholar 

  6. Glinka A, Wu W, Delius H et al (1998) Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391:357–362

    Article  PubMed  CAS  Google Scholar 

  7. Wu W, Glinka A, Delius H, Niehrs C (2000) Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol 10:1611–1614

    Article  PubMed  CAS  Google Scholar 

  8. Niida A, Hiroko T, Kasai M et al (2004) DKK1, a negative regulator of Wnt signaling, is a target of theβ-catenin/TCF pathway. Oncogene 23:8520–8526

    Article  PubMed  CAS  Google Scholar 

  9. Gonzalez-Sancho JM, Aguilera O, Garcia JM et al (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of β-catenin/TCF and is downregulated in human colon cancer. Oncogene 24:1098–1103

    Article  PubMed  CAS  Google Scholar 

  10. Wirths O, Waha A, Weggen S et al (2003) Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms’ tumors. Lab Invest 83:429–434

    PubMed  CAS  Google Scholar 

  11. Forget MA, Turcotte S, Beauseigle D et al (2007) The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types. Br J Cancer 96:646–653

    Article  PubMed  CAS  Google Scholar 

  12. Yamabuki T, Takano A, Hayama S et al (2007) Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67:2517–2525

    Article  PubMed  CAS  Google Scholar 

  13. Yu B, Yang X, Xu Y et al (2009) Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas. J Hepatol 50:948–957

    Article  PubMed  CAS  Google Scholar 

  14. Voorzanger-Rousselot N, Goehrig D, Journe F et al (2007) Increased Dickkopf-1 expression in breast cancer bone metastases. Br J Cancer 97:964–970

    PubMed  CAS  Google Scholar 

  15. Hall CL, Kang S, MacDougald OA et al (2006) Role of Wnts in prostate cancer bone metastases. J Cell Biochem 97:661–672

    Article  PubMed  CAS  Google Scholar 

  16. Shizhuo W, Tao J, Shulan Z et al (2009) The expression and significance of Dickkopf-1 in epithelial ovarian carcinoma. Int J Biol Markers 24:165–170

    PubMed  Google Scholar 

  17. Torres MP, Ponnusamy MP, Lakshmanan I et al (2009) Immunopathogenesis of ovarian cancer. Minerva Med 100:385–400

    PubMed  CAS  Google Scholar 

  18. Harrison ML, Jameson C, Gore ME (2008) Mucinous ovarian cancer. Int J Gynecol Cancer 18:209–214

    Article  PubMed  CAS  Google Scholar 

  19. Gómez-Raposo C, Mendiola M, Barriuso J et al (2010) Molecular characterization of ovarian cancer by gene-expression profiling. Gynecol Oncol 118:88–92

    Article  PubMed  Google Scholar 

  20. Jarboe JS, Johnson KR, Choi Y et al (2007) Expression of interleukin-13 receptor α2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res 67:7983–7986

    Article  PubMed  CAS  Google Scholar 

  21. Hao XP, Pretlow TG, Rao JS et al (2001) Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 61:8085–8088

    PubMed  CAS  Google Scholar 

  22. Endo Y, Beauchamp E, Woods D et al (2008) Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol Cell Biol 28:2368–2379

    Article  PubMed  CAS  Google Scholar 

  23. Xia Y, Karin M (2004) The control of cell motility and epithelial morphogenesis by Jun kinases. Trends Cell Biol 14:10–94

    Article  Google Scholar 

  24. Friedl P, Wolf K (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3:362–374

    Article  PubMed  CAS  Google Scholar 

  25. Wang W, Goswami S, Lapidus K et al (2004) Identification and testing of a gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64:8585–8594

    Article  PubMed  CAS  Google Scholar 

  26. Seoud M, Salem Z, Shamseddine A et al (1999) Papillary serous carcinoma of the ovary following prolonged tamoxifen treatment. Eur J Gynaecol Oncol 20:237–239

    PubMed  CAS  Google Scholar 

  27. Vivas-Mejia P, Benito JM, Fernandez A et al (2010) c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer. Clin Cancer Res 16:184–194

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This article was supported by national nature science fund of China (No. 30973191).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shulan Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, S., Zhang, S. Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion. Clin Exp Metastasis 28, 581–591 (2011). https://doi.org/10.1007/s10585-011-9393-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-011-9393-9

Keywords

Navigation